Upregulation of transcription factors controlling MHC expression in multiple sclerosis lesions

GLIA

Volumn 36, Issue 1, 2001, Pages 68-77

  Hila, Sorana ^a   Soane, Lucian ^a   Koski, Carol Lee ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

CIITA; HLA class I; HLA class II; RFX5; Transcriptional regulation

Indexed keywords

TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; BRAIN; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GLIOSIS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX; METABOLISM; MICROGLIA; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELINATED NERVE; PATHOLOGY; PHYSIOLOGY; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; BRAIN; FEMALE; GENE EXPRESSION REGULATION; GLIOSIS; HUMANS; IMMUNOHISTOCHEMISTRY; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROGLIA; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE FIBERS, MYELINATED; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 0034800712     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.1096     Document Type: Article

References (48)

1. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis
2. Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions
3. Activation of NF-κB and c-Jun transcription factors in multiple sclerosis lesions
4. Cellular immune response in multiple sclerosis plaques
5. Balancing function vs. self defence: The CNS as an active regulator of the immune response
6. Regulation of MHC class II expression in the central nervous system
7. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions
8. Expression of transforming growth factor (TGF)-β1, -β2 and -β3 isoforms and TGF-β type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures
9. Post-mortem MRI-guided sampling of multiple sclerosis brain lesions: Increased yield of active demyelinating and (p)reactive lesions
10. The bare lymphocyte syndrome: Molecular clues to the transcriptional regulation of major histocompatibility complex class II genes
11. Microglia in the immune surveillance of the brain: Human microglia constitutively express HLA-DR molecules
12. Microglia: Intrinsic immuneffector cell of the brain
13. Site α is crucial for two routes of IFN-γ induced MHC class I transactivation: The ISRE mediated route and a novel pathway involving CIITA
14. The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and β2-microglobulin genes
15. The role of enhancer A in the locus-specific regulation of classical and non-classical HLA class I genes by NF-κB
16. Transactivation of classical and nonclassical HLA class I genes through the IFN-stimulated response element
17. Microglia as mediators of inflammatory and degenerative diseases
18. Transcription factor NF-κB and IκBα are localized in macrophages in active multiple sclerosis lesions
19. Astrocytic factors deactivate antigen presenting cells that invade the central nervous system
20. The pathology of multiple sclerosis: A historical perspective
21. Tumor necrosis factor identified in multiple sclerosis brain
22. Detailed in vivo analysis of interferon-γ induced major histocompatibility complex expression in the central nervous system: Astrocytes fail to express major histocompatibility complex class I and II molecules
23. Interpreting MHC class I expression and class I/class II reciprocity in the CNS: Reconciling divergent findings
24. Microglia-derived macrophages in early multiple sclerosis plaques
25. Induction of MHC class I expression by the MHC class II transactivator CIITA
26. Activation of the MHC class II transactivator CIITA by interferon-γ requires cooperative interaction between Stat1 and USF-1
27. Differential selectivity of CIITA promoter activation by IFN-γ and IRF-1 in astrocytes and macrophages: CIITA promoter activation is not affected by TNF-α
28. The role of nitric oxide in multiple sclerosis
29. Identification of distinct regions of 5′ flanking DNA that mediate constitutive, IFN-γ, STAT1, and TGF-β-regulated expression of the class II transactivator gene
30. Mechanisms of inflammation in MS tissue: Adhesion molecules and chemokines
31. The Bare Lymphocyte Syndrome and the regulation of MHC expression
32. Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis
33. Regulation of class II MHC expression
34. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions
35. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients
36. Indictment of the microglia as the villain in multiple sclerosis
37. Regulation of MHC gene expression
38. Pathogenesis of tissue injury in MS lesions
39. HLA class II molecules (HLA-DR, -DP, -DQ) on cells in the human CNS studied in situ and in vitro
40. Phenotypic differences between human monocytes/macrophages and microglial cells studied in situ and in vitro
41. Shared regulatory elements in the promoters of MHC class I and class II genes
42. Regulation of transcription of MHC class I and MHC class II genes: Differences and similarities
43. The common regulatory pathway of MHC class I and class II transactivation
44. Axonal loss in multiple sclerosis lesions: Magnetic resonance imaging insights into substrates of disability
45. Staging of multiple sclerosis (MS) lesions: Pathology of the time frame of MS
46. Is there a balance between microglia and astrocytes in regulating Th1/Th2-cell responses and neuropathologies?
47. Chemokine and chemokine receptors in the pathogenesis of multiple sclerosis
48. Molecular mechanisms of microglial activation